Tina K Thethi1, Aster Sigel2, Shanker Japa3, Bonnie Katalenich3, Shuqian Liu3, Tuyen Nguyen4, Joshua Larrazolo5, Stephanie Syu6, Esther Carefoot7, Roberta McDuffie3, Vivian Fonseca8. 1. Translational Research Institute, AdventHealth, Orlando, FL, United States of America. Electronic address: Tina.Thethi.MD@AdventHealth.com. 2. Nevada State College, Henderson, NV, United States of America. 3. Tulane University Health Sciences Center, New Orleans, LA, United States of America. 4. Ochsner Medical Center, New Orleans, LA, United States of America. 5. Louisiana State University Health Sciences Center, New Orleans, LA, United States of America. 6. American Family Children's Hospital-University of Wisconsin, Madison, WI, United States of America. 7. University of Ottawa, Ottawa, Canada. 8. Tulane University Health Sciences Center, New Orleans, LA, United States of America; Southeast Louisiana Veterans Health Care Systems, New Orleans, LA, United States of America.
Abstract
BACKGROUND: Obesity is a global epidemic and prevalence of obesity is higher in African Americans (AAs) compared to Caucasians. The endocannabinoid system (EC) and polymorphism in the endocannabinoid receptor type 1 (CNR1) gene 3813A/G and 4895A/G and in the fatty acid amide hydrolase (FAAH) are associated with obesity. The objective was to explore racial and sex differences in these polymorphisms and the biochemical abnormalities seen in obesity. METHODS: A cross-sectional study of 667 subjects (53.67% female; 49.18% AA; 69.72% were obese (body mass index [BMI] ≥30)) were screened for CNR1 3813, 4895 and FAAH 385 polymorphisms using a real-time polymerase chain reaction (PCR) system. RESULTS: Subjects with FAAH 385 polymorphisms were more likely to be obese (75.14% vs. 67.81, P = 0.046). There were no significant sex differences for CNR1 3813 and CNR1 4895; or between obese and control group. AAs had higher prevalence of CNR1 3813 (OR, 2.80, 95% CI, 1.95-4.04) and FAAH 385 (OR, 2.48, 95% CI, 1.82-3.38). Association between African American race and the three genotypes persisted after adjustment of all the variables (P < 0.001). CONCLUSION: FAAH 385 polymorphism is more likely seen in obese and in older subjects. AAs had higher prevalence of CNR1 3813 and FAAH 385 polymorphisms; and lower prevalence of CNR1 4895 polymorphism. These findings may explain some of the racial differences, but not the sex differences in the clinical expression of obesity.
BACKGROUND:Obesity is a global epidemic and prevalence of obesity is higher in African Americans (AAs) compared to Caucasians. The endocannabinoid system (EC) and polymorphism in the endocannabinoid receptor type 1 (CNR1) gene 3813A/G and 4895A/G and in the fatty acid amide hydrolase (FAAH) are associated with obesity. The objective was to explore racial and sex differences in these polymorphisms and the biochemical abnormalities seen in obesity. METHODS: A cross-sectional study of 667 subjects (53.67% female; 49.18% AA; 69.72% were obese (body mass index [BMI] ≥30)) were screened for CNR1 3813, 4895 and FAAH 385 polymorphisms using a real-time polymerase chain reaction (PCR) system. RESULTS: Subjects with FAAH 385 polymorphisms were more likely to be obese (75.14% vs. 67.81, P = 0.046). There were no significant sex differences for CNR1 3813 and CNR1 4895; or between obese and control group. AAs had higher prevalence of CNR1 3813 (OR, 2.80, 95% CI, 1.95-4.04) and FAAH 385 (OR, 2.48, 95% CI, 1.82-3.38). Association between African American race and the three genotypes persisted after adjustment of all the variables (P < 0.001). CONCLUSION:FAAH 385 polymorphism is more likely seen in obese and in older subjects. AAs had higher prevalence of CNR1 3813 and FAAH 385 polymorphisms; and lower prevalence of CNR1 4895 polymorphism. These findings may explain some of the racial differences, but not the sex differences in the clinical expression of obesity.
Authors: Paola Russo; Pasquale Strazzullo; Francesco P Cappuccio; David A Tregouet; Fabio Lauria; Maria Loguercio; Gianvincenzo Barba; Marco Versiero; Alfonso Siani Journal: J Clin Endocrinol Metab Date: 2007-04-03 Impact factor: 5.958
Authors: Steven E Nissen; Stephen J Nicholls; Kathy Wolski; Josep Rodés-Cabau; Christopher P Cannon; John E Deanfield; Jean-Pierre Després; John J P Kastelein; Steven R Steinhubl; Samir Kapadia; Muhammad Yasin; Witold Ruzyllo; Christophe Gaudin; Bernard Job; Bo Hu; Deepak L Bhatt; A Michael Lincoff; E Murat Tuzcu Journal: JAMA Date: 2008-04-01 Impact factor: 56.272
Authors: Wolfgang Lieb; Alisa K Manning; Jose C Florez; Josée Dupuis; L Adrienne Cupples; Jarred B McAteer; Ramachandran S Vasan; Udo Hoffmann; Christopher J O'Donnell; James B Meigs; Caroline S Fox Journal: Obesity (Silver Spring) Date: 2009-01-22 Impact factor: 5.002
Authors: Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop Journal: Philos Trans R Soc Lond B Biol Sci Date: 2022-07-11 Impact factor: 6.671